- Home
- TARS vs PPLI Comparison
TARS vs PPLI Comparison
Compare TARS & PPLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | PPLI |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 2.9B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TARS | PPLI |
|---|---|---|
| Price | $69.88 | $40.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $99.80 | $56.80 |
| AVG Volume (30 Days) | 589.3K | ★ 1.3M |
| Earning Date | 11-03-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 48.21 | ★ 79.97 |
| EPS | N/A | ★ 5.65 |
| Revenue | $451,360,000.00 | ★ $4,365,235,000.00 |
| Revenue This Year | $61.17 | N/A |
| Revenue Next Year | $26.47 | $0.70 |
| P/E Ratio | ★ N/A | $7.10 |
| Revenue Growth | ★ 146.71 | N/A |
| 52 Week Low | $53.89 | $35.38 |
| 52 Week High | $91.53 | $48.32 |
Technical Indicators
Market Signals| Indicator | TARS | PPLI |
|---|---|---|
| Relative Strength Index (RSI) | 39.09 | 52.86 |
| Support Level | $69.47 | $37.56 |
| Resistance Level | $73.45 | $42.29 |
| Average True Range (ATR) | 2.85 | 1.04 |
| MACD | -0.68 | -0.01 |
| Stochastic Oscillator | 0.91 | 39.94 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
About PPLI People Incorporated Common Stock
People Inc is a media and publishing business that operates a portfolio of brands, including PEOPLE, Food & Wine, Travel + Leisure, InStyle, Better Homes & Gardens, and Southern Living. The company also holds a minority equity stake in MGM Resorts International.